Sensitizing oral squamous cell carcinoma to chemotherapy by targeted disruption of cancer stem cells using an NFκB inhibitor

Prof Pablo Agustin Vargas,Dr. Luan César da Silva,Prof. Rogério Moraes Castilho
DOI: https://doi.org/10.1016/j.oooo.2024.04.048
2024-07-14
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Abstract:Oral squamous cell carcinoma (OSCC) shows a limited response to current systemic treatments, and this resistance could be associated with cancer stem cells (CSC). NFκB is an activated pathway in several malignancies, including head and neck cancer. Here we evaluated the role of NFκB inhibitor on the behavior of CSC derived from OSCC.
dentistry, oral surgery & medicine
What problem does this paper attempt to address?